Damora Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMRA and other ETFs, options, and stocks.About DMRA
Damora Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2.
DMRA Key Statistics
Stock Snapshot
As of today, Damora Therapeutics(DMRA) shares are valued at $24.64. The company's market cap stands at 1.49B, with a P/E ratio of -5.40.
As of 2026-05-07, Damora Therapeutics(DMRA) stock has fluctuated between $24.45 and $25.39. The current price stands at $24.64, placing the stock +0.8% above today's low and -2.9% off the high.
Damora Therapeutics(DMRA) shares are trading with a volume of 10.35K, against a daily average of 179.03K.
In the last year, Damora Therapeutics(DMRA) shares hit a 52-week high of $38.33 and a 52-week low of $2.45.
In the last year, Damora Therapeutics(DMRA) shares hit a 52-week high of $38.33 and a 52-week low of $2.45.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.